BriaCell Therapeutics presented findings at ESMO 2026 showing that changes in PD-L1 expression on circulating cancer-associated macrophage-like cells (CAMLs) correlate with progression-free and overall survival in metastatic breast cancer patients undergoing immunotherapy. The pooled analysis of 111 heavily pretreated patients revealed that PD-L1 levels after treatment initiation, rather than baseline levels, better predict clinical outcomes. These results support further research into CAML PD-L1 as a biomarker to guide immunotherapy decisions, including BriaCell's Bria-IMT regimen, which is currently in a pivotal Phase 3 trial. Positive Phase 2 data and FDA Fast Track designation highlight the potential impact on metastatic breast cancer treatment.
BriaCell's metastatic breast cancer biomarker research is the subject, with Pluang's Health sector data providing market context. As of Oct 23, 2026 17:41 WIB, 42 of 150 Health-sector US stocks rose while 97 fell. Notable movers include NUWE at USD 0.53 with a 7.63% gain and 100% buy order activity, and TNGX at USD 29.86 up 6.91%, both with strong buy interest on Pluang.
FS Bancorp, Inc. has appointed Matthew D. Mullet as a director on the boards of both the company and its bank, 1st Security Bank of Washington, effective October 22, 2026. Mullet, who has been President since 2024 and CEO since 2025-2026, brings exte...
The global protein ingredients market, valued at $42.3 billion in 2025, is projected to grow to $65 billion by 2032 with a CAGR of 6.3%. Growth is driven by rising consumer demand for health-focused, protein-enriched foods, sports nutrition, and sust...
AX1 has launched Console 2.0, a platform on the Base blockchain that lets AI agents perform tasks and get paid in USDC using the x402 payment standard by Coinbase. This new version simplifies setup, allowing users to deploy AI agents quickly to work ...
The global generator cooling systems market is projected to grow from $3.76 billion in 2026 to $5.03 billion by 2031 at a CAGR of 6.0%. Growth is fueled by rising demand for reliable backup and continuous power in expanding data centers, industrial f...
The global computed tomography (CT) market is undergoing significant innovation driven by photon-counting technology, AI integration, mobile imaging, and point-of-care applications. These advancements are enhancing image quality, workflow efficiency,...
